Clopidogrel og den cirkulerende hovedmetabolit binder reversibelt in vitro til humane plasmaproteiner (henholdsvis 98% og 94%).
Clopidogrel and the main circulating metabolite bind reversibly in vitro to human plasma proteins (98% and 94% respectively).